Records containing: Renal Cell Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-07-23The Influence of Type of Anesthesia on Recurrence of Renal Cell Carcinoma After Nephrectomy: a Prospective Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2024-07-22A Phase IIB, Open Label, Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies, Scheduled to Receive Immunotherapy (IOT) as a Single Agent or Combination, to Predict Response to Therapy
-
CLINICAL_TRIALS study record update · 2024-07-09An Open-Label, Multicenter, Phase 1 Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-Tumor Activity of RO7515629 in Participants With Unresectable and/or Metastatic HLA-G Positive Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-07-05A Phase 1 Multiple-Dose Study to Evaluate the Safety and Tolerability of XmAb®23104 in Subjects With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-07-03A Phase 1B, Open Label, Dose-finding Study to Evaluate the Safety and Tolerability of Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-07-01Collection of Blood, Fluid, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer or Normal Volunteers
-
CLINICAL_TRIALS study record update · 2024-06-25A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2024-06-18Novel Prognostic Markers in Renal Cancer: a Protocol for the Analysis of Paraffin Embedded Tumour Samples
-
CLINICAL_TRIALS study record update · 2024-06-17A Phase 1, Multiple-Dose, Dose-Escalation Trial of PT2385 Tablets, a HIF-2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2024-06-13A Phase 1b, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of Camidanlumab Tesirine (ADCT-301) as Monotherapy or in Combination in Patients With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-06-04Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.
-
CLINICAL_TRIALS study record update · 2024-05-29Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients Based on "Guideline for Re-examination of New Drugs"
-
CLINICAL_TRIALS study record update · 2024-05-24A Phase 1 Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2024-05-07A Phase 1, Open-label Study to Evaluate the Safety and Tolerability of BMC128 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer (NSCLC), Melanoma or Renal Cell Carcinoma (RCC)
-
CLINICAL_TRIALS study record update · 2024-05-0689Zr-bevacizumab PET Imaging in Patients With Renal Cell Carcinoma Treated With Sunitinib or Bevacizumab Plus Interferon; a Pilot Study
-
CLINICAL_TRIALS study record update · 2024-05-06Visualizing VEGF Producing Lesions in Von Hippel-Lindau Disease
-
CLINICAL_TRIALS study record update · 2024-04-30Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma Based on Accurate Genotyping: a Population-based Study
-
CLINICAL_TRIALS study record update · 2024-04-26UPCC06820 Phase 1 Trial of Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary
-
CLINICAL_TRIALS study record update · 2024-04-25A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Refractory or Relapsed Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-04-15Identification and Validation of Plasma Diagnostic Biomarkers for Multi-Cancer Based on Metabolomics: A Multi-Center Clinical Research and Validation Trial
-
CLINICAL_TRIALS study record update · 2024-04-12Retrospective and Perspective Analysis of Short, Medium and Long Term Clinical Performance of Patients Undergoing MicrowaveThermal Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
-
CLINICAL_TRIALS study record update · 2024-04-10European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)
-
CLINICAL_TRIALS study record update · 2024-04-05Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
-
CLINICAL_TRIALS study record update · 2024-04-02Study on the Optimal Number of Fiducial Marker Implanted With 3D-template Assitance for Stereotactic Body Radiotherapy
-
CLINICAL_TRIALS study record update · 2024-04-01A Phase 1/1b Dose Escalation/Expansion Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors